Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of November 2019. The document serves as a transaction notification regarding insider trading activities by Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them, rather than a financial results report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions.
| Transaction Date | Insider Name | Position | Transaction Type | Volume | Price (GBP) |
|---|---|---|---|---|---|
| 2019-11-01 | Mr N Hirons | SVP, Global Ethics and Compliance | Sale | 5,789.956 | 17.52 |
| 2019-11-01 | Mr R Connor | President, Global Vaccines | Sale | 6,200 | 17.5260 |
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely discloses two separate sales of ordinary shares executed on the London Stock Exchange.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is restricted to regulatory disclosure of share sales.
Investor Verification Checklist
- Verify the total number of shares sold by Mr N Hirons and Mr R Connor on November 1, 2019.
- Confirm the transaction prices of approximately £17.52 per share against the market price on the London Stock Exchange for that date.
- Check subsequent filings to determine if these sales were part of a pre-arranged trading plan.
- Review the company's latest Form 20-F for comprehensive financial performance data, as this Form 6-K contains no financial metrics.